267
Participants
Start Date
January 8, 2018
Primary Completion Date
August 6, 2018
Study Completion Date
August 17, 2018
Leu Sil 1.0mg
Leu 1100 mg + 1mg Sil BID
Leu Sil 4.0mg
Leu 1100 mg + 4mg Sil BID
Leu Met Sil 1.0mg
Leu 1100 mg + Met 500mg + 1mg Sil BID
Leu Met Sil 4.0mg
Leu 1100 mg + Met 500mg + 4mg Sil BID
Placebo
Placebo
Medical Research South, Charleston
AMR, Mobile
Premier, Clarksville
Rapid Medical Research, Cleveland
Synexus, Chicago
Synexus, St Louis
Clinical Trials Management, Metairie
Pennington Biomedical Research Center, Baton Rouge
Synexus, Dallas
Synexus, San Antonio
ACR, Meridian
ACR, Jordan
AMR, Las Vegas
Catalina Research Institute, Montclair
Northern California Research, Sacramento
Lead Sponsor
NuSirt Biopharma
INDUSTRY